| scholarly article | Q13442814 |
| P50 | author | Dieter Seebach | Q91415 |
| P2093 | author name string | Katherine Thompson | |
| Nirupam Purkayastha | |||
| Heinz E Moser | |||
| Stefania Capone | |||
| Albert K Beck | |||
| Jennifer Leeds | |||
| P2860 | cites work | Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases | Q27655501 |
| Type IIA topoisomerase inhibition by a new class of antibacterial agents | Q27663884 | ||
| Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance | Q27664216 | ||
| Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents | Q28306539 | ||
| Chemical and Biological Investigations ofβ-Oligoarginines | Q29400511 | ||
| Drugs for bad bugs: confronting the challenges of antibacterial discovery | Q29547723 | ||
| Molecular cloning of apicoplast-targeted Plasmodium falciparum DNA gyrase genes: unique intrinsic ATPase activity and ATP-independent dimerization of PfGyrB subunit | Q30042495 | ||
| Delivery of antimicrobials into parasites | Q30493563 | ||
| Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery | Q31577177 | ||
| Cell-permeable peptides induce dose- and length-dependent cytotoxic effects | Q33290661 | ||
| Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding | Q33556083 | ||
| Cell penetrating peptides in the delivery of biopharmaceuticals | Q33649501 | ||
| On the mechanism of eukaryotic cell penetration by α- and β-oligoarginines--targeting infected erythrocytes | Q33801301 | ||
| Cell-penetrating peptides: breaking through to the other side | Q34032300 | ||
| Conceptually new entries into cells | Q34144858 | ||
| Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. | Q34214929 | ||
| Cell-penetrating peptides: classes, origin, and current landscape | Q34215571 | ||
| Permeation through phospholipid bilayers, skin-cell penetration, plasma stability, and CD spectra of α- and β-oligoproline derivatives | Q34557817 | ||
| Real-time analysis of uptake and bioactivatable cleavage of luciferin-transporter conjugates in transgenic reporter mice. | Q35973247 | ||
| Thirty years of Escherichia coli DNA gyrase: from in vivo function to single-molecule mechanism. | Q36775907 | ||
| Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus | Q36787714 | ||
| Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. | Q36854231 | ||
| Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters | Q36858404 | ||
| Mycobacterium tuberculosis DNA gyrase as a target for drug discovery | Q36985660 | ||
| Function-oriented synthesis, step economy, and drug design | Q37045266 | ||
| The design of guanidinium-rich transporters and their internalization mechanisms. | Q37047226 | ||
| Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges | Q37277330 | ||
| Single-molecule motions of oligoarginine transporter conjugates on the plasma membrane of Chinese hamster ovary cells | Q37300525 | ||
| Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery | Q37974719 | ||
| Cell entry of cell penetrating peptides: tales of tails wagging dogs | Q38003743 | ||
| Cell-penetrating peptides as a novel transdermal drug delivery system | Q38030731 | ||
| Cell-penetrating peptides: 20 years later, where do we stand? | Q38106559 | ||
| Is there a future for cell-penetrating peptides in oligonucleotide delivery? | Q38129998 | ||
| A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. | Q38344289 | ||
| Beta-peptidic peptidomimetics | Q38572449 | ||
| Inhibition of herpes simplex virus type 1 infection by cationic beta-peptides | Q38899213 | ||
| Inhibitory effect of short cationic homopeptides against gram-positive bacteria | Q39062153 | ||
| Zwitterionic guanidine-based oligomers mimicking cell-penetrating peptides as a nontoxic alternative to cationic polymers to enhance the cellular uptake of micelles | Q39285812 | ||
| Live-cell analysis of cell penetration ability and toxicity of oligo-arginines | Q40037287 | ||
| ADME investigations of unnatural peptides: distribution of a 14C-labeled beta 3-octaarginine in rats | Q40192102 | ||
| Ratiometric activatable cell-penetrating peptides provide rapid in vivo readout of thrombin activation | Q41550368 | ||
| MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficile | Q42281252 | ||
| A unique 45-amino-acid region in the toprim domain of Plasmodium falciparum gyrase B is essential for its activity | Q42612505 | ||
| Improved efficacy of fosmidomycin against Plasmodium and Mycobacterium species by combination with the cell-penetrating peptide octaarginine | Q42710241 | ||
| Transduction of peptides and proteins into live cells by cell penetrating peptides | Q42807094 | ||
| Cellular uptake studies with beta-peptides | Q42817065 | ||
| Translocation of a beta-peptide across cell membranes | Q43855224 | ||
| Synthesis and antibacterial activity of conjugates between norfloxacin and analogues of the siderophore vanchrobactin | Q43855991 | ||
| Norfloxacin-poly(L-lysine citramide imide) conjugates and structure-dependence of the drug release | Q45129230 | ||
| Effects of conformational stability and geometry of guanidinium display on cell entry by beta-peptides | Q46383269 | ||
| Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation | Q46454374 | ||
| Bacterial cell penetration by beta3-oligohomoarginines: indications for passive transfer through the lipid bilayer | Q46456003 | ||
| Arginine magic with new counterions up the sleeve | Q46461442 | ||
| Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides | Q46623720 | ||
| Enantiomeric and diastereoisomeric (mixed) L/ D-octaarginine derivatives - a simple way of modulating the properties of cell-penetrating peptides | Q48021428 | ||
| Permeation of a beta-heptapeptide derivative across phospholipid bilayers. | Q50929221 | ||
| Interaction of alpha-and beta-oligoarginine-acids and amides with anionic lipid vesicles: a mechanistic and thermodynamic study. | Q52570584 | ||
| Exploring the antibacterial and hemolytic activity of shorter- and longer-chain beta-, alpha,beta-, and gamma-peptides, and of beta-peptides from beta2-3-aza- and beta3-2-methylidene-amino acids bearing proteinogenic side chains--a survey. | Q54449459 | ||
| HeLa Cell Entry by Guanidinium-Rich β-Peptides: Importance of Specific Cation–Cell Surface Interactions | Q57350872 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 179-193 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Chemistry and Biodiversity | Q15761289 |
| P1476 | title | Antibacterial activity of enrofloxacin and ciprofloxacin derivatives of β-octaarginine. | |
| P478 | volume | 12 |
| Q58616701 | A dual function antibiotic-transporter conjugate exhibits superior activity in sterilizing MRSA biofilms and killing persister cells |
| Q40203926 | Bifunctional antimicrobial conjugates and hybrid antimicrobials |
| Q92581739 | Cell Penetration, Herbicidal Activity, and in-vivo-Toxicity of Oligo-Arginine Derivatives and of Novel Guanidinium-Rich Compounds Derived from the Biopolymer Cyanophycin |
| Q41717540 | Interaction of β(3) /β(2) -peptides, consisting of Val-Ala-Leu segments, with POPC giant unilamellar vesicles (GUVs) and white blood cancer cells (U937)--a new type of cell-penetrating peptides, and a surprising chain-length dependence of their vesi |
| Q55407405 | Modifications of quinolones and fluoroquinolones: hybrid compounds and dual-action molecules. |
Search more.